The new nomenclature unifies the terms NMO and NMO spectrum disorders (NMOSD) further divided into NMOSD with AQP4-IgG, without AQP4-IgG, and with unknown AQP4-IgG status. The gene discussed is AQP4; the disease is neuromyelitis optica.